Buehlmann Laboratories AG

BUHLMANN has become the leading calprotectin company within a few years, offering the widest range of calprotectin products for automation: BUHLMANN FCAL® ELISA and Quantum Blue® quantitative calprotectin rapid tests, as well as the new immunoturbidimetric BUHLMANN FCAL® Turbo assay. For automated ELISA robots, we will continue to support our new CE-certified protocol BUHLMANN FCAL® ELISA, combined with our convenient, safe, and clean fecal sampling and extraction device, CALEX® Cap. With the IB Doc® smartphone-based home testing solution for calprotectin, BÜHLMANN is providing patients with calprotectin monitoring. In 2016, BUHLMANN launched its latest innovation, the Quantum Blue® Infliximab rapid test, enabling clinicians to directly measure trough levels.